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In this article second trimester amniotic ﬂuid biomarkers are mea-
sured for correlation with preterm delivery. One additional milliliter of
amniotic ﬂuid is collected during amniocentesis for dosages of IL-6,
MMP-9, CRP and glucose levels, along with maternal serum CRP and
glucose. MMP-9 and Il-6 levels were measured with the corresponding
Human QuantikineR ELISA Kit (R&D systems) according to the
instructions provided by the manufacturer. Cut-off values for AF MMP-
9 and IL-6 were ﬁxed by the kit sensitivity thresholds.
Data includes ROC curves for glucose (Fig. 1), IL-6 (Fig. 2) and
MMP-9 (Fig. 3), aiming to search for sensitivity and speciﬁcity in the
prediction of premature delivery. Statistical analyses are performed
with SPSS v20.0 software. Statistical signiﬁcance is determined using
the Mann–Whitney and one way ANOVA test. The association with
preterm delivery is performed using a two proportions test. Correla-
tions are measured using the Pearson'’s coefﬁcient. A p valueo0.05 is
considered statistically signiﬁcant. The data is presented in the ﬁgures
provided. Data relied on a previous publication “Prediction of preterm
delivery by second trimester inﬂammatory biomarkers in the amniotic
ﬂuid” (A. Kesrouani, E. Chalhoub, E. El Rassy, M. Germanos, A. Khaz-
zaka, J. Rizkallah, E. Attieh, N. Aouad, 2016) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.cyto.2016.06.008
srouani).
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areaCytokines in amniotic ﬂuidype of data Figures
ow data was
acquiredLaboratory dosage of biomarkers using QuantikineR ELISA Kit (R&D systems)ata format Analyzed
xperimental factors Amniotic and plasma levels of biomarkers
xperimental
featuresCorrelation between biomarker levels at 2nd trimesters amniocentesis and
preterm deliveryata source location Hotel-Dieu de France University Hospital, Beirut, Lebanon
ata accessibility The data are within this articleD
Value of the data
 Amniotic levels of interleukin-6, MMP-9, glucose and CRP could be markers of preterm delivery.
 The data are useful for selecting which of the inﬂammatory biomarkers in the amniotic ﬂuid could
indicate future premature labor.
 The data may provide a diagnostic opportunity for anticipating and preventing premature
deliveries.
 Methodology can be used for further assessment of correlation between amniotic biomarkers and
preterm delivery.1. Data
Amniotic levels of interleukin-6, MMP-9 and CRP are evaluated for risk of preterm delivery. Data
includes comparison between levels of term and preterm cases. ROC curves for glucose (plasmatic
and intra-amniotic), IL-6 and MMP-9 are presented (Figs. 1–3).2. Experimental design, materials and methods
Data are from of a prospective cohort series at the Obstetrics Department of Hotel Dieu de France
University Hospital, Lebanon. It includes patients having a mid-trimester amniocentesis. Indications
include advanced maternal age, increased ﬁrst trimester nuchal translucency, abnormal second tri-
mester biochemical screening test and positive ultrasound soft markers associated with maternal
anxiety. Cases with multiple pregnancies, clinical signs of infection or later diagnosis of fetal aneu-
ploidies were excluded. The number of patients enrolled was deﬁned in accordance to the budget
allocated by the research council of our institution. This pilot research was approved by the Insti-
tutional Review Board of the Faculty of Medicine of Saint Joseph University and eligible patients
signed an informed consent for this purpose.
During amniocentesis one additional milliliter of AF was stored for later dosages of IL-6, MMP-9,
CRP and glucose levels along with maternal serum CRP and glucose. The data results were not dis-
closed to both the physician and the patient. MMP-9 and Il-6 levels were measured with the corre-
sponding Human QuantikineR ELISA Kit (R&D systems) according to the instructions provided by the
manufacturer. Cut-off values for AF MMP-9 and IL-6 were ﬁxed by the kit sensitivity thresholds and
the cutoff was set for AF MMP-9415 ng/mL and AF IL-641430 pg/mL. The cut-off for serum CRP was
9 mg/L and for AF CRP was 0.155 mg/L. No microbiological examination was done because of
administrative reasons and because our patients were asymptomatic. All patients were screened for
group B streptococcus colonization and bacterial vaginosis with vaginal swab and those who were
Fig. 2. ROC curve for IL-6 levels in predicting preterm labor.
Fig. 1. ROC curves for amniotic and plasma glucose levels in predicting preterm labor.
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Fig. 3. ROC curve for MMP-9 levels in predicting preterm labor.
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delivery.
Statistical analyses for mean 7 standard deviation are performed with SPSS v20.0 software.
Statistical signiﬁcance is determined using the Mann–Whitney and one way ANOVA test. The asso-
ciation between the level of the inﬂammatory markers and the incidence of preterm delivery is
performed using a two proportions test. Correlations are measured using the Pearson's coefﬁcient. A p
valueo0.05 is considered statistically signiﬁcant [1].Transparency document. Supplementary material
Transparency data associated with this article can be found in the online version at http://dx.doi.
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